1. Introduction {#sec0005}
===============

The continuing increase in the degree of bacterial resistance to conventional antibiotics is a problem of global significance. The crisis of antimicrobial resistance has been ascribed to the misuse of these agents and today resistant strains are common, such as methicillin-resistant *Staphylococcus aureus,* vancomycin-resistant enterococci, drug resistant *Streptococcus pneumoniae* and *Mycobacterium tuberculosis*, carbapenem-resistant and extended-spectrum beta-lactamase producing enterobacteria, multidrug-resistant *Pseudomonas aeruginosa* and *Acientobacter baumannii etc.* It was estimated that the medical cost per patient with an antibiotic-resistant infection is up to \$29,069 and infections are usually life treating ([@bib0940]; [@bib0065]). Similarly, fungi have become resistant to poliens, azoles and echinocandins, and the emergence of drug-resistant strains has been reported in all fungal species ([@bib0795]). Beside the noticeable emergence of resistant protozoa and viruses, there is a problem with limited number of antiprotozoal and antiviral agents ([@bib0370]; [@bib0505]). This highlights the necessity for examination of new antimicrobial agents and treatment strategies of infections caused by the mentioned microorganisms.

The plant kingdom represents the source of various medicines. Indeed, since ancient times medicinal plants play an important role of health care population and could represent a significant source of new antimicrobial drugs for combating pan- and multi-drug resistant microorganisms. These new antimicrobial agents could be hidden in medicinal plant extracts and essential oils. One of the significant medicinal plants is *Eucalyptus camaldulensis*. Thus, this review represents the summary of previous researches data, regarding chemical composition, antimicrobial activity, and other significant effects of *Eucalyptus camaldulensis*.

1.1. *Eucalyptus camaldulensis* Dehn. (1832) {#sec0010}
--------------------------------------------

The River Red Gum (*Eucalyptus camaldulensis* Dehn.) is a tree belonging to the genus *Eucalyptus* from Myrtaceae family. This family includes 140 genera and about 3800 species distributed in tropical and subtropical regions of the world ([@bib0045]). The genus *Eucalyptus* was described and named in 1788 by the French botanist l'Héritier. The name is generic, from the Greek words 'eu' (well) and 'kalyptos' (covered), because the flowers of various *Eucalyptus* species are protected by an operculum ([@bib0905]). The genus is indigenous to Australia and Tasmania, consists of over 800 species, spreading worldwide and successfully introducing due to its easy adaptability and fast growth ([@bib0260]). As a consequence, *Eucalyptus* has become one of the world's most widely planted genera ([@bib0035]) and a plantation species in many parts of the world ([@bib0050]; [@bib0700]).

*Eucalyptus camaldulensis* (formerly *Eucalyptus rostrata* Schl.), also known as long beak eucalyptus, murray red gum, red gum, river gum, and red river gum, is one of the most widely distributed *Eucalyptus* species. It is also considered one of the most widely planted trees in the world (*ca*. 5 000 000 ha planted) ([@bib0715]; [@bib0135]). *Eucalyptus camaldulensis* species is named for a private estate garden near the Camaldoli monastery near Naples (L\'Hortus Camaldulensis di Napoli), from where the first specimen came to be described. Material from this tree was used by Frederick Dehnhardt, Chief Gardener at the Botanic Gardens in Naples, to describe this species in 1832 ([@bib0870]).

The habitus of the plant is very specific. Life form of *Eucalyptus camaldulensis* is a single-stemmed tree, with large trunk ([Fig. 1](#fig0005){ref-type="fig"} ). It is medium-sized to tall tree, average height 30 m ([@bib0140]), although some authors record trees to 45 m ([@bib0135]; [@bib0150]). Leaves are grey-blue, alternate, drooping, 8--22 cm long, 1--2 cm wide, often curved or sickle shaped, tapering, and short pointed at base. Fruit is very small capsules at the end of thin stalks, 5--8 mm, valves 4, and containing minute seeds. *Eucalyptus camaldulensis* is an evergreen, perennial plant, and according to [@bib0520] it could reach ages of 500--1000 years. Commonly grows on riversides, whether of permanent or seasonal water ([@bib0150]), generally dominate in the community, forming pure open forests or woodlands ([@bib0265]).Fig. 1*Eucalyptus camaldulensis* (river red gum) on the Murchison River in Western Australia (by courtesy of Prof. Stephen D. Hopper).Fig. 1

The species *Eucalyptus camaldulensis* consists of two variations: *E. camaldulensis* var. *camaldulensis* and *E. camldulensis* var. *obtuse* Blakely, and one subspecies *Eucalyptus camaldulensis* subsp. *simulata* Brooker & Kleinig ([Table 1](#tbl0005){ref-type="table"} ), found in North Queensland, which has been recognised as a hybrid of *E. camldulensis* var. *obtusa* and *Eucalyptus tereticornis* Smith ([@bib0145]). According to the Centre for Plant Biodiversity Research ([@bib0390]), the operculum shape in *E. camaldulensis* is highly variable ([Table 1](#tbl0005){ref-type="table"}). In the past, this character has been used to break up the group into different varieties or subspecies. The entire complex is currently under revision and new varieties or subspecies may be described or extant ones rationalised. Until this work is completed, [@bib0390] decided to adopt a conservative view of *E. camaldulensis*.Table 1The main characters that distinguish *Eucalyptus camaldulensis* taxa.Table 1TaxonBarkLeavesOperculum*E. camaldulensis* var. *camaldulensis*grey-white, rough at base bark![](fx1_lrg.gif)non-glaucous, green, narrowly lanceolate juvenile leaves![](fx4_lrg.gif)strongly beaked 0.3-0.7 cm long![](fx7_lrg.gif)*E. camaldulensis* var. *obtusa*essentially white, smooth and seasonally powdery bark![](fx2_lrg.gif)dull to slightly glossy green adult leaves with densely to very denselyreticulate venation![](fx5_lrg.gif)rounded or obtusely conical operculum 0.4-0.7 cm long at maturity and glaucous juvenile growth![](fx8_lrg.gif)*E. camadulensis* subsp. *simulata*grey-white, smooth to base bark![](fx3_lrg.gif)ovate or lanceolate juvenile leaves, adult leaves with dense reticulation![](fx6_lrg.gif)long horn-shaped operculum 0.9--1.6 cm long![](fx9_lrg.gif)

1.2. *Eucalyptus camaldulensis* traditional and contemporary application {#sec0015}
------------------------------------------------------------------------

Used for centuries as a traditional Aboriginal herbal remedy, eucalyptus leaves and their essential oils have found various applications in everyday life due to their antiseptic, anti-inflammatory and antipyretic properties ([@bib0535]; [@bib0600]). Ancient Aboriginal society in Australia used *E. camaldulensis* plant in medicines to treat gastrointestinal symptoms (including colic, diarrhea, and dysentery), respiratory disease (colds, coughs, asthma, laryngalgia, laryngitis, pharyngitis, sore throat, trachalgia), arrest bleeding, open wounds, and cuts, as well as its decoctions for the relief of spasms, aches, and pains in muscles, but also pains in joints and even tooth ([@bib0325]).

As previously stated, *E. camaldulensis* plant is also known as red gum eucalyptus, murray red gum, and river red gum, because it produces red kino *i.e.* red gum, in significant amount. Thus besides different plant parts Aborigines used its secondary products as folk remedies. They made incisions in the tree trunks for obtaining the red kino and applied it directly to abrasions and cuts. Except fresh kino, the dried, dehydrated kino was prepared and used in the same way as fresh, but after softening in water ([@bib0960]; [@bib0240]). Another significant folk remedy is young leaves which were used for smoke bath, where burning leaves smoke surrounds patient. The smoking medicine was used for fevers, colds, flu and general sickness ([@bib0960]; [@bib0775]; [@bib0325]). Being useful for treating various health conditions, *E. camaldulensis* and its folk remedies then were transferred and introduced to other parts of the world, such as Africa. In Sudan the red kino was used for sore throat and diarrhea, while the smoke of burnt leaves was inhaled in case of respiratory problems. In Senegal for stomach-ache decoctions from leaves were prepared with sugar, while in Zimbabwe for cough, flu, and fever a decoction of *E. camaldulensis* leaves were combined with *Citrus limon* (L.) Burm. f. fruits and *Psidium guajava* L. leaves ([@bib0315]; [@bib0670]). Further more, to prevent tooth decay and periodontitis in Nigeria teeth cleaning sticks were made from tree ([@bib0165]), and in traditional medicine for healing wound infections, poultice of leaves containing eucalyptus oil have been used ([@bib0020]).

Nowdays, *E. camaldulensis* has been the subject of numerous studies, to confirm plant's usefulness in traditional medicine for the treatment of various ailments ([@bib0250]; [@bib0430]; [@bib0515]). Its essential oils are reported to be anesthetic, antiseptic and astringent ([@bib0535]; [@bib0600]). In addition, a decoction of the leaves is reported to be a remedy for sore throat and other bacterial infections of the respiratory and urinary tracts ([@bib0160]). Due to numerous contemporary data regarding the antimicrobial activity of *E. camaldulensis*, this subject will be discussed in special section/chapter.

Except antimicrobial effects, *E. camaldulensis* plant extracts (PEx) and essential oils (EOs) and its constituents possess numerous other beneficial effects. One such effect is certainly gastrointestinal effect. In animal models, extracts of the leaves of *E. camaldulensis* and *E. torelliana* R. Muell are reported to decrease gastric acid production and thus appear useful for the treatment of gastric ulcers ([@bib0020]). It has been proven that *E. camaldulensis* leaves methanol extracts possessed ulcer-healing promoting effect when investigated in acetic acid induced-ulcer in rat (*Rattus norvegicus domesticus*) ([@bib0620]) ([Table 2](#tbl0010){ref-type="table"} ). Similarly, the poultice of the leaves is applied over wounds and ulcers ([@bib0445]).Table 2Different significant effects of *Eucalyptus camaldulensis*.Table 2Different *E. camaldulensis* effectsModel organism and/or cell linePlant part extract, oil or compoundEffect of dosage and/or application modeReferenceGastrointestinal effectAcetic acid induced-ulcer in ratLeaves methanol extractsReduction the size from day 5 in animals treated with 500 mg/kg body weight of reconstituted extracts at 24 h interval[@bib0620])Four ruminal fistulated buffaloes (*Syncerus caffer*), 4 years old with initial body weight 321 ± 20 kgLeaves mealDietary treatments - different levels of leaf meal supplementation at 0, 40, 80, and 120 g/hd/d for 21 days.[@bib0910])Protozoa count and proteolytic bacteria population were reduced (p \< 0.05). Fungal spores, amylolytic, cellulolytic and total viable bacteria were unchanged.  Anti-inflammatory and analgesic effectHealthy albino rats (200 ± 30 g)Seed essential oils of *E. camaldulensis* var. *nancy* and *E. camaldulensis* var. *petford*Carrageenan induced paw oedema test model in rats, which received 1000 μg kg^−1^ body weight; 43.75-87.5% of anti-inflammatory activity[@bib0730])Anti-nociceptive activitiesHealthy albino rats (200 ± 30 g)Seed essential oils of *E. camaldulensis* var. *nancy* and *E. camaldulensis* var. *petford*Rats treated with 1000 μg kg^−1^ body weight, measured neurogenic and inflammatory pain responses, 41.03-99.09% of inhibition[@bib0730])Cytotoxic effectTwo human breast cancer cell lines (MCF 7 and MDA-MB-231)Leaves methanol, ethyl acetate, n-buthanol, and water extractsSignificant cytotoxic potential with IC50 values ranging from 3 to 250 μg/mL after 72h[@bib0490])L20B (a genetically engineered mouse cell line) and human rhabdomyo sarcoma cellsCrude methanol extractsModerate cytotoxicity[@bib0030])Ehrlich\'s ascites carcinoma (EAC) in Swiss albino miceStem bark methanol extract25, 50 and 100 mg/kg/day for 5 days; High LD50 value (1120 mg/kg)[@bib0510])  Anti-parasitic, insecticidal and repellent effects*Trypanosoma brucei* infected miceLeaves, stem and root barks extracts200-600 mg/kg body weight/day of the hexane, ethyl acetate, methanol and water extracts for 21consecutive days[@bib0555])Promastigotes of *Leishmania major in vitro*Methanol and aqueous extractsIC50 values were 586.2 ± 47.6 and 1108.6 ± 51.9 μg/mL[@bib0725])Larvicidal activity against *Anopheles stephenssi*Leaves extract and volatile oilLC50 values of 89.85 and 397.75 ppm, respectively. Clear dose-response relationships, the highest dose of 320 ppm essential oil extract resulted almost in 100% mortality in the population after 24 h of exposure[@bib0675])Mosquito larvicidal against two mosquito species, *Aedes aegypti* and *Aedes albopictus*Leaves essential oils and their 12 constituents400, 200, 100, 50, and 25 μg/mL of essential oil were tested and each compound was tested at 50, 25, 12.5, and 6.25 μg/mL; Mortality was recorded after 24 h; LC50 values 31.0-55.3 lg/mL, LC90 values 71.8-192.4 lg/mL.[@bib0220])*Aphis gossypii* Glover (Hem: Aphididae)Essential oilLC~50~values 2.28 μl L^−1^air[@bib0330])Repellency against the adult females of *Culex pipiens*Dried fruits essential oilTwo different treatment levels (5 and 10 μl) in six exposure times (15, 75, 135, 195, 255 and 315 s)[@bib0375])  Anti-diabetic effectAlbino ratsLeaves ethanol extractOral 500 mg/kg of body weight[@bib0285])Alloxan-induced diabetic ratsLeaves ethanol extract500 mg/kg of body weight in distilled water orally, *E. camaldulensis* leaves supplement incorporated into the diet 5 g/kg/day[@bib0290])

The antioxidant effect represents one more useful *E. camaldulensis* characteristic. The free radical scavenging activities of the essential oils is assessed by measuring their scavenging abilities for 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals. The scavenging activity for the *Eucalyptus camaldulensis* was characterized as high (81.9%) ([@bib0425]). The results of *E. camaldulensis* EO antioxidant effect evaluation indicated that the EO had high potent ferrous ions chelating and total antioxidant activities comparing to ascorbic acid and BHT ([@bib0345]). Also, the *E. camaldulensis* var. *brevirostris* leaves ethanol extract possessed antioxidant activity, where the prevailing antioxidants in the extract were gallic and ellagic acid ([@bib0360]). There are several more studies dealing with antioxidant activity of *E. camaldulensis* ([@bib0095]; [@bib0815]; [@bib0860]; [@bib0730]), but it is interesting to mention here that *E. camaldulensis* flower EO inhibited melanogenesis through its antioxidant properties and by down-regulating both mitogen-activated protein kinases (MAPK) and protein kinase A (PKA) signaling pathways. This study indicated that the essential oil has the potential to be developed into a skin care product ([@bib0495]). Thus, except the medical application, *E. camaldulensis* extracts are also currently used in cosmetic formulations, and leaf extracts have been approved as food additives ([@bib0900]). Also, essential oils and their constituents have been used as flavoring agents in the formulation of different pharmaceutical products, cosmetics, and food industry ([@bib0280]). Except this, *E. camaldulensis* PEx and EOs have the potential to be used as antibacterial and antifungal agents in cosmetic and pharmaceutical products. It is interesting to mention here the activity of *E. camaldulensis* EOs (2--8 mg/mL) on dental biofilm formation *in vivo* where detected inhibition was 14.5--39.2% after four weeks, comparing to chlorhexidine (2 mg/mL), which inhibited maximum 13.9% of dental biofilm formation ([@bib0785]). Extracts and essential oils of this aromatic plant can be used as food preservatives in order to reduce the dependency on synthetic chemicals in food preservation. In Australia, it is also used as sources of wild honey, providing bees with good quality pollens and heavy yields of nectar ([@bib0135]). Moreover, in industry, the wood of *E. camaldulensis* has been used for heavy construction, railway sleepers, flooring, framing, fencing, plywood, and veneer manufacture, wood turning, firewood, and charcoal production ([@bib0135]). Eucalyptus camaldulensis wood burns well and make a good fuel, also its dense wood and coppicing ability make it an excellent species for fuelwood production used in several countries such as Brazil ([@bib0525]; [@bib0350]). Furthermore, *Eucalyptus* biomass residues from agro-forest and pulping industries represent a valuable source of high-value compounds such as triterpenic compounds ([@bib0310]; [@bib0410]).

Due to the diversity of *E. camaldulensis* beneficial effects, all effects reported in the literature are summarized in [Table 2](#tbl0010){ref-type="table"}. Beside the beneficial effects, essential oils and plant extracts can exert potentially unfavorable effects as complex mixtures of different compounds. A risk assessment of their hazard is always necessary before commercialization, so the estimation of EOs toxicity has been already conducted resulting in human oral and dermal dose limit recommendations. For most EOs the recommended dose is in range 1--4%, but for cineole-rich *Eucalyptus* sp. EOs, including *E. camaldulensis*, the limit dose is 10%, indicating a generally low application risk ([@bib0640]). The safe daily oral dose in human adults is 300--600 mg, while semisolid preparations for topical use may contain 5--20% of *Eucalyptus* oil ([@bib0125]; [@bib0920]). Similarly, *E. camaldulensis* bark methanolic extract LD50 value for Swiss albino mice (*Mus musculus*) is very high -- 1120 mg/kg, indicating its low host toxic effects ([@bib0510]). The low toxicity and natural origin of *E. camaldulensis* essential oil and extracts, in contrast to synthetic antimicrobials, favor their application as antimicrobial agents.

2. Chemical composition {#sec0020}
=======================

2.1. *Eucalyptus camaldulensis* plant chemical composition {#sec0025}
----------------------------------------------------------

*Eucalyptus camaldulensis* leaves contain 0.1--0.4% essential oil, of which 77% is 1,8-cineole. There is considerable amount of cuminal, phellandrene, aromadendren (or aromadendral), valerylaldehyde, geraniol, cymene, and phellandral ([@bib0270]Council of Scientific and Industrial Research, 1948--1976; [@bib0870]). Leaves contain 5--11% tannin. The kino (a class of wood exudates), contains 45% kinotannic acid as well as kino red, a glucoside, catechol, and pyrocatechol. Leaves and fruits test positive for flavonoids and sterols. The bark contains 2.5--16% tannin, the wood 2--14%, and the kino 46.2--76.7% ([@bib0955]). Some of the reported phytoconstituents of the tree included essential oils, sterols, alkaloids, glycosides, flavonoids, tannins, and phenols.

2.2. *Eucalyptus camaldulensis* essential oil chemical composition {#sec0030}
------------------------------------------------------------------

A considerable variation in the yield of leaf essential oil from *E. camaldulensis* has been reported ([@bib0135]; [@bib0840]; [@bib0695]; [@bib0405]), depending on multiple biotope factors, and also genetic and/or epigenetic characteristics of the plant. The yields of *E. camaldulensis* leaves EO (0.90--0.98%) originating from Pakistan and Morocco were similar ([@bib0060]; [@bib0405]), while [@bib0695] reported a variable oil content of 0.6--1.4% from different locations of Benin. The oil yield of *E. camaldulensis* from Jerusalem was 0.5% ([@bib0200]) and significantly higher oil yield was reported for *E. camaldulensis* from Taiwan: 2.3--3.0% with respect to different seasons ([@bib0840]). Similar EOs yield (0.77--2.53%) has been reported for *E. globulus*, as one of the economically important plants for essential oil production ([@bib0540]; [@bib0835]; [@bib0470]). The reported essential oil yield for other *Eucalyptus* species is slightly higher, ranging from 1.2% to 3% (w/w): the highest yield was obtained from *E. cinerea* F. Muell. ex Benth and *E. sideroxylon* A. Cunn. ex Woolls (3.0%), followed by *E. lehmannii* (Schauer) Benth. (2.8%), *E. bicostata* Maiden, Blakely & J.H.Simmonds (2.0%), *E. leucoxylon* F. Muell (1.6%), *E. maidenii* F.Muell. (1.5%), and *E. astringens* Maiden (1.2%) ([@bib0830]).

All the *E. camaldulensis* essential oil single compounds belong to chemical class of hydrocarbons terpenes, further devided according to the number of isoprene units (C~5~H~8~) to monoterepenes (C~10~H~16~), sesquterepenes (C~15~H~24~), and longer chains of isoprene units. Oxygenated terpenes (oxygenated monoterepenes and oxygenated sesquterepenes) are called trepenoids. According to the literature, in *E. camaldulensis* EOs dominates 1,8-cineole (eucalyptol), *trans*-pinocarveol and terpinen-4-ol from chemical class of oxygenated monoterepenes. The oils also contain considerable amount of monoterpene hydrocarbons (β-pinene, α-thujene, γ-terpinene, p-cymene), while sesquterepene hydrocarbons and oxygenated sesquterepenes are detected in significantly lower amounts ([Table 3](#tbl0015){ref-type="table"} ).Table 3Classes of major *Euclyptus camaldulensis* essential oils compounds and their content in different plant parts.Table 3Chemical classesChemical subclassesSublaclasses content in leaf and fruit (%)[a](#tblfn0005){ref-type="table-fn"}Major essential oils compoundsMajor compounds content in oil[a](#tblfn0005){ref-type="table-fn"}, [b](#tblfn0010){ref-type="table-fn"}LFrFlTerpenesMonoterpene hydrocarbons5.7-52.2 Lα-Pinene1.7-28.31.12-33.5118.7 Frβ-Pinene0.3-18.68.87.7-27.0918.5 Flα-Thujene1.0-3.40.30.6-0.77β-Phellandrene0.5-7.50.32.1-2.2p-Cymenetr. -6.54.89.32γ-Terpinene0.19-7.60.20.4-0.5Sesquiterpene hydrocarbons1.8-3.6 LAromadendrene0.1-110.20.21-0.246.1 Fr*allo*-Aromadendrene0.2-130.21.2 F^•^lBicyclogermacrene0.3-1.820.09-0.4α-Copaene0.9tr.--  TerpenoidsOxygenated monoterpenes40.8-87.42 L1,8-Cineole13.73-84.93.834.7-69.2614.1 Fr*trans*-Pinocarveol0.06-8.50.20.11-1.950 FlTerpinen-4-ol0.27-5.21.93.29-3.6Myrtenol1.4-9.752.10.12Cuminal0.09-3.21.30.94-1.01Oxygenated sesquiterpenes4.9-39.6 LSpathulenol0.16-19.2190.12-10.1823.2 FrElemol0.6-3----12.7 Flβ-Eudesmol0.13-4.4----*cis*-Farnesol0.9-5--0.1[^1][^2]

When the composition of five *Eucalyptus* essential oils (*Eucalyptus camaldulensis*, *Eucalyptus astringens* Maiden, *Eucalyptus leucoxylon*, *Eucalyptus lehmannii* and *Eucalyptus rudis* Endl) are compared, a high percentage of monoterpenes, mainly oxygenated compounds, with lower quantities of sesquiterpenes were recorded throughout the four seasons ([@bib0110]). In *E. camaldulensis* oil, monoterpenes were prevalent (34.6--56.3% for all seasons) while sesquiterpene hydrocarbons (6.6--16.5%) and oxygenated sesquiterpenes (2.1--11.1%) were present in less extent. *Eucalyptus astringens* oil had resembling chemical characteristic to *E. camaldulensis* oil, the abundant quantity of monoterpenes, which represented more than 50% of the total oil amounts for the all seasons (53.4--63.6 %). Similarlly, *E. leucoxylon* essential oil, contained mainly oxygenated monoterpenes with a prevalence of 1,8 cineole (13.1--17.6%), such as in *E. camaldulensis* oil (15.5--20.6%). The essential oil of *E. lehmannii* also was made up largely of monoterpenes (hydrocarbons 27.6--44.9% and oxygenated 30.9--62.8%), with smaller amounts of sesquiterpene hydrocarbons and absence of oxygenated sesquiterpenes, unlike the oils of other *Eucalyptus* species ([@bib0110]).

The difference in the chemical composition of the *E. camaldulensis* EOs may be due to many reasons, which can generally be classified in five main groups: (1) the change in plant genes through generations and hybridizations (naturally and induced) may result in production a variety of volatile oils compared with those of different habitat; (2) nutrients of different soils and their accumulation in the leaves may result in different plant metabolism and consequently production of different bio-products and also EOs made of diverse compounds in variable amounts; (3) acclimation of species to the Australian environment in which it is growing in the past, compared with the introduced and/or worldwide planted trees on plantations; (4) different ecotypes of the *E. camaldulensis* and (5) differences may be due to plant part used for essential oils extraction and its stage of development (maturity). Knowing that these factors express significant effect on the percent compositions of some EO components for this species, *E. camaldulensis* can be grown in the corresponding areas and in specific conditions to enhance EO production.

The variations in the chemical composition of eucalyptus EOs with respect to seasons have also been reported ([@bib0925]), but the most commonly detected as major components in the eucalyptus essential oil are 1,8-cineole, β-pinene, γ-terpinene, and p-cymene. It is important to emphasize here that according to chemical composition the *Eucalyptus camaldulensis* EO generally can be divided in two different types. Type I is a cineole-rich essential oil containing 80--90% 1,8-cineole plus pinene, and Type II is a cineole-poor essential oil, containing significantly less cineol ([@bib0960]). Plant genotype is important factor influencing the final chemical composition of EO ([@bib0305]). Due to genetic and epigenetic factors same plant species can produce a similar EO, but with different chemical composition and therapeutic activities. [@bib0155] examined essential oils of two variations, *Eucalyptus camaledulensis* var. *camaldulensis* and *Eucalyptus camaledulensis* var. *obtuse*, and the main compounds of *Eucalyptus camaledulensis* var. *camaldulensis* were p-cymene (22%), cryptone (14%), and spathulenol (17%), while *Eucalyptus camaledulensis* var. *obtusa* had different main compounds: 1,8-cinole (52%), α-pinene (15%), and aromadendrene (3%), suggesting that these subspecies belong to different types of eucalyptus essential oils. The content of 1,8-cineole was also variable but in the same range for essential oils reported from Greece (25.3--44.2%) ([@bib0925]), Pakistan (34.4--40.0%) ([@bib0060]), Mozambique (37.1--40.0%) ([@bib0770]), Nigeria (32.8--70.4%) ([@bib0750]), and Taiwan (34.0--68.2%) ([@bib0840]). Similarly, the major component of Eucalyptus camaldulensis oils originating form Burundi, Morocco, and Benin was 1,8-cineole ranging from 31.0 to 72.5% with no presence of cryptone ([@bib0300]; [@bib0990]; [@bib0995]; [@bib0695]). Cryptone has been shown to be present in low-cineole varieties of EOs from Australia ([@bib0120]), Uruguay ([@bib0295]) and South Florida ([@bib0760]). For example, the major constituents identified in the essential oil from South Florida included p-cymene (35.0%), cryptone (13.7%), terpinen-4-ol (5.7%), spathulenol (4.3%), and cuminaldehyde (3.7%), with a very low amount of 1,8-cineole (2.7%) ([@bib0760]).

It was proven that essential oils of different plant parts have different chemical composition ([Table 3](#tbl0015){ref-type="table"}). Previous studies on the essential oil of *E. camaldulensis* flowers revealed the presence of 1,8-cineole, β-pinene, and spathulenol as the most abundant constituents ([@bib0440]). The essential oil of the leaves was found to contain *p*-cymene, γ-terpinene, α-pinene, 1,8-cineole, terpinen-4-ol, α-terpineol, carvacrol, and thymol as the major components ([@bib0860]). The major components of the fruits essential oil were aromadendrene, α-pinene, drimenol, and cubenol ([@bib0355]).

Plant developmental stage and maturity of plant parts used for essential oil extraction also affect essential oil chemical composition. [@bib0440] analyzed the immature flowers and calli grown in Athens (Greece), and they found that the main monoterpenes produced in *E. camaldulensis* calli, cultured in darkness and under light conditions, were 1,8-cineole, 62.70 and 69.26% as well as β-pinene, 27.09 and 25.31%, respectively. In lower amounts α-pinene (1.2 and 1.1%, respectively) and the terpenoids, camphene, myrcene, isocineole, myrtenol, bicyclogermacrene, spathulenol, and *trans*-pinocarveol were present (less than 1%). Apart from isocineole, these constituents were also determined in the essential oil from immature flowers. This is remarkable because [@bib0440] showed that undifferentiated calli are capable of producing high amounts of monoterpenoid compounds (approx. one third of that produced by the explant). This makes immature flowers from *E. camaldulensis* an interesting candidate for the development of calli able to produce high percentages of these two important monoterpenes, 1,8-cineole and β-pinene ([@bib0440]). Also, the influence of light conditions on essential oil chemical composition showed that light conditions did not considerably affect the production of monoterpenes and sesquiterpenes compounds by calli developed from immature flowers ([@bib0440]).

Furthermore, plant culture conditions can influence the essential oil chemical composition. Soil salinity is a key ecological stress that severely influences plant productivity ([@bib0960]). [@bib0060] showed that salinity had a considerable effect on the percent compositions of some components of *E. camaldulensis* leaves essential oil. The mean values of 1,8-cineole content of EO from saline and non-saline provenances of Pakistan were 34.42 and 40.05%, respectively ([@bib0060]). Therefore, they recommend stressing of this species by growing in the saline areas to enhance essential oil production for its various medicinal and pharmacological uses.

2.3. *Eucalyptus camaldulensis* extracts chemical composition {#sec0035}
-------------------------------------------------------------

Extraction represents the primary step in obtaining the crude mixture of compounds from plants. Quality and quantity of the extracts dependent of the target compound structures, natural sources, and type of processes ([@bib0560]), explaining the different phenolic composition in the extracts obtained with different procedures. The most commonly plant extract have been obtained by conventional solvent extraction methods (infusion, decoction, digestion, maceration, and percolation) ([@bib0075]) using solvents such as water, ethanol, methanol, chloroform, dimethyl-sulfoxide *etc.* However, these techniques are demanding regarding the extraction process duration, organic solvent consumption, and lack of extraction automation. The potential and powerful alternative to conventional liquid solvent extraction methods are Ultrasonic-Assisted Extraction (UAE) and Microwave-Assisted Extraction (MAE), especially in the case of plant material ([@bib0465]; [@bib0380]). Interest in MAE has increased significantly over the past 5--10 years in particular medicinal plant research, as a result of its inherent advantages as special heating mechanism, moderate capital cost, and its good performance under atmospheric conditions ([@bib0090]; [@bib0205]). In addition, MAE technique possesses many advantages compared with other methods for the extraction of compounds such as bioactive compounds ([@bib0825]) saving in processing time and solvent, higher extraction rate, better products with lower cost, reduced energy consumption (up to 85-fold savings), and waste generation ([@bib0970]; [@bib0975]). This is confirmed for *E. camaldulensis* extraction of phenolic and flavonoid compounds, where the compounds were extracted with MAE for 5 min which was equivalent with UAE (60 min) and traditional extraction (24 h) methods ([@bib0435]).

Many authors reported the chemical composition of *E. camaldulensis* extracts. The leaves of *E. camaldulensis* from the zoo-botanical garden in Giza (Egypt) yielded 4 major fractions ([@bib0850]). The major components of the first fraction (eluted with water) were identified as HHDP-glucopyranose, chlorogenic acid, and phloroglucinol derivatives. The second 30% methanol fraction was found to contain different galloyl-HHDP-glucopyranose positional isomers and pedunculagin as major components. The third 60% methanol fraction was predominantly composed of digalloyl-HHDP-glucopyranose (tellimagrandin I) α and β anomers, while the last 100% methanol fraction was composed of a mixture of ellagitannin dimers. The profiling of the obtained fractions by HPLC--PDA--ESI/MS/MS indicated that ellagitannins were the most predominant components of all three methanol fractions ([@bib0850]).

The secondary metabolites screening of *E. camaldulensis* leaf extracts from Nigeria confirmed presence of tannin, saponins, and cardiac glycosides ([@bib0070]). Analyzed *n*-hexane, chloroform, and methanol extracts of *E. camaldulensis* stem bark and leaf also grown in Nigeria showed the presence of tannins and saponins in the stem bark and in the leaf of *E. camaldulensis* with absence of alkaloids in all extracts ([@bib0025]). Furthermore, the crude methanol leaf extracts also from Nigeria contained in addition volatile oils and balsam (gum) ([@bib0080]). Similarly, the phytochemical screening of ethanol, methanol, and petroleum ether leaf extracts from Nigeria contained in moderate to high amount secondary metabolites: alkaloids, saponins, tannins, flavonoids, steroid, carbohydrates, and cardiac glycosides, and not anthraquinones ([@bib0235]). Crude methanol leaf extracts of *E. camaldulensis* from Iran had saponins, tannins, volatile oils, and balsam (gum), while the components such as anthraquinones, hydrolysable tannin, flavonoid, alkaloid, and glycosides were not detected ([@bib0545]); crude methanolic leaves extract of *E. camaldulensis* from India contained anthraquinones, flavonoids, saponins, and terpenoids, while alkaloids, cardiac glycosides, and tannins were not detected ([@bib0855]). Phytochemical screening of the crude stem barks methanol extract of *E. camaldulensis* from Bangladesh indicated presence of saponins, flavonoids, tannins, and also volatile oils, while anthraquinones, hydrolysable tannins, alkaloids, and glycosides were not present ([@bib0510]). The polyphenolic composition (flavonoids and phenolic acids and aldehydes) also was studied in the soluble fractions of the methanolic extracts of *Eucalyptus camaldulensis* originating from two Spain provinces, Huelva and Pontevedra: gallic, protocatechuic, vanillic and ellagic acids, and protocatechic aldehyde were identified, along with eriodictyol, quercetin, naringenin, vanillin, naringin, quercitrin, luteolin, and kaempferol ([@bib0175]). *Eucalyptus camaldulensis* extracts are generally rich in tannins which vary qualitatively and quantitatively according to the origin of the samples, and consequently protoanthocyanidin levels were influenced by the geographical origin ([@bib0175]).

3. Antimicrobial effect of *Eucalyptus camaldulensis* extracts and essential oils {#sec0040}
=================================================================================

Antimicrobial activity of *E. camaldulensis* EO and extracts are well documented against many microorganisms listed in the [Table 4](#tbl0020){ref-type="table"} . For easier comparison, all data commented here for EOs were re-calculated from microliter per milliliter or microgram/milligram per milliliter to percentage (v/v or w/v), using the equitations presented in [Fig. 2](#fig0010){ref-type="fig"} . We considered here only minimal inhibitory and minimal bactericidal concentrations, while results obtained using disc or agar diffusion methods were not discussed. However, MIC/MBC results vary between several micrograms to several milligrams. Such high variation does not seem as real, even taking into account variation in oil composition, and are rather a consequence of erroneous equalization of one microliter and one microgram, or typographical errors. For instance, there are some nonsense MICs, such as 2000 μL/mL, that is practically impossible to obtain ([@bib0815]). In some manuscripts even a species was not precisely indicated ([@bib0475]; [@bib0565]; [@bib0950]; [@bib0895]) and these results were not considered in the present review.Table 4Antimicrobial activity of *E. camaldulensis* essential oils and extracts.Table 4*E. camaldulensis*MicroorganismActivity[a](#tblfn0015){ref-type="table-fn"}Recalculated (%)ReferencesMICMBCMICMBCEssential oilLeaves essential oil (%, v/v) from Northern Cyprus*S. aureus*0.5[@bib0035]*L. monocytogenes*, *E. durans*, *Salmonella* Typhi, *E. coli*, *B. subtilis*, *P. aeruginosa*\>1Leaves essential oil (μg/mL) from Iran*S. aureus*, *E. coli*80.0008[@bib0630]Leaves essential oil (μg/mL) from Iran*S. aureus*3.93.9-7.80.000390.00039-- 0.00078Panahi et al. (2011)Leaves essential oil (μL/mL) from Ethiopia*Trichophyton* sp.2.5--5.00.27--0.53[@bib0720]*Microsporum*, *Candida* Rhodotorula5.00.53*A. niger*2.50.27*E. coli*, *Shigella* sp, *Bacillus* sp, streptococci5.00.53Essential oil (μg/mL) from Iran*P. aeruginosa* ATCC 27853641280.00640.0128[@bib0745]Leaves essential oil (%) from Iran*S.aureus, A. baumannii*0.10.2[@bib0735]*E.coli*0.150.25*P. vulgaris*0.250.35*S. sonnei*0.300.45*P. aeruginosa*0.20.40*K. pneumonia*0.050.15*S. eneterica* serovar. Typhi0.40.6*S. eneterica* serovar. Paratyphi0.350.45*S. eneterica* serovar. Enteritidis, Infantis0.60.8Leaves essential oil (mg mL^-1^) from Iran*Streptococcus mutans*, *S. pyogenes*120.10.2[@bib0785]Leaves essential oil (mg mL^-1^) from Thailand*T. cucumeris*, *F. oxysporum*, *C. globosum*50.5[@bib0865]*A. niger*, *C. cladosporioides*, *F. palustris*, *P. citrinum*, *T. versicolor*101*R. oryzae*\>10\>1Leaves essential oil (μl mL^-1^) from MontenegroReference *Acinetobacter baumannii* and MDR clinical strains0.5--10.7--40.05--0.10.07--0. 4[@bib0595]*S. aureus* ATCC 25923, *E. coli* ATCC 2592211--20. 10.1--0.2Leaves essential oil (μl/mL) from Kenya*Fusarium sp.*7--88--100.7--0.850.85--1[@bib0415]Leaves essential oil (μl/mL) from Algeria*F. graminearum*2.50.27[@bib0680]*F. sporotrichioide*1.250.13Leaves essential oil (μg mL^-1^) from Brazil*S. aureus*10000.1[@bib0210]*E. coli*\>1000\>0.1Leaves essential oil from Egypt% of reduction[@bib0345]Rotavirus Wa strain50Coxsackievirus B453.3Herpes virus type 190Adenovirus type 70EOs in vegetable oil (mg/mL)Trypanosoma brucei brucei and Trypanosoma evansi10010[@bib0460]Leaves essential oil (mg/mL) from Syria*S. aureus*0.20.80.020.8[@bib0580]*B. subtilis*1.6--3.21.6--3.20.16--0.320.16--0.32*M. luteus*0.2--0.40.4--1.60.02--0.040.04--0.16*S. pyogenes*0.4--0.80.8--1.60.04--0.080.08--0.16*K. pneumonia*1.6--3.23.20.16--0.320.32*V. parahaemolyticus*0.10.20.010.02*S. Typhimurium*1.6--3.23.20.16--0.320.32*E. coli*0.4--3.20.8--3.20.04--0.320.08--0.32*P. vulgaris, Ps. aeruginosa*\>12.8\>12.8\>1.28\>1.28Leaves essential oil from IranGI[@bib0570]*P. ultimum, R. solani, B. sorokiniana, C. gloeosporioides*100%*P. digitatum, A. flavus*0%  Plant extractLeaves acetone extract (mg/l) from NigeriaMDR *Staphylococcus aureus*20--500.002--0.005[@bib0500]Leaves methanol extract (mg/mL) from EgyptMDR *S. aureus*0.780.078[@bib0790]MDR *P. aeruginosa*3.120.312Bark butanol extract (μg mL^-1^) from Egypt*Pectobacterium cartovorum*160.0016[@bib0365]*Ralstonia solanacearum*1250.0125*Agrobacterium tumefaciens*2500.025*Dickeya* spp.5000.05Leaves methanol extracts (mg/mL) from India*S. aureus, B. subtilis*50.5[@bib0780]*P. aeruginosa*, *S. eneterica* serovar. Paratyphi101.0*P. vulgaris, K. pneumonia,*252.5*S. eneterica* serovar. Typhi505.0*E. coli*757.5Leaves crude methanolic extracts  (μg mL^-1^) from Egypt*Dickeya solani, B. cereus*0.080.160.0000080.000016[@bib0340]*S. aureus*0.220.400.0000220.00004Leaves methanol, ethanol, and petroleum ether extracts (mg mL^-1^) from Nigeria*P. aeruginosa*1002001020[@bib0235]*B. subtilis*50--200200--4005--2020-40*E. coli*50--200100--2005--2010--20*Penicillium expansum*50--10050--4005--105--40*C. albicans*50--20050--2005--205--20Leaves methanol--dichloromethane extracts (mg mL^-1^) from Japan*S. aureus*, methicillin-resistant *S. aureus*0.0630.0063[@bib0900]*B. cereus*, *E. faecalis*, *Propionibacterium acnes*, *Trichophyton mentagrophytes*0.1250.0125*E. coli*, *Pseudomonas putida*, *Alicyclobacillus acidoterrestris*\>0.250\>0.0250Leaves crude methanol extracts (μg mL^-1^) from Nigeria*B. subtilis*, *C. albicans*, *S. aureus* (ATCC103207), *S. aureus* (clinical)2000.02[@bib0080]*E. coli* (ATCC 10418), *P. aeruginosa* (ATCC 27853), *S.* Typhi\>200\>0.02Leaves methanol extract (mg mL^-1^) from Nigeria*Klebsiella spp, Salmonella* Typhi*, P. aeruginosa*101.0[@bib0070]Leaves dichloromethane fraction (mg mL^-1^) from Nigeria*S. aureus*1.250.125*Yersinia enterocolitica*0.1570.0157*B. subtilis*0.040.004*Klebsiella spp, Salmonella* Typhi*, P. aeruginosa*101.0*S. aureus, Yersinia enterocolitica*0.6250.0625*B. subtilis*0.790.079Leaves crude n-hexane extracts; crude chloroform leaves and steam extracts (μg mL^-1^) from Nigeria*Helicobacter pylori* ATCC43504 and ATCC47619\<25\<0.0025[@bib0025]Steam crude n-hexane extracts (μg mL^-1^) from Nigeria\<12.5\<0.00125Leaves and steam bark hexane, chloroform, methanol extracts (μg/mL) from Nigeria*Mycobacterium tuberculosis* H37Rv4--52.20.0004--0.0064[@bib0615]Leaves methanol extracts 80% (μg/mL) from Ethiopia*M. tuberculosis*6.25--500.000625--0.005[@bib0420]*M. bovis*12.5--500.00125--0.005Leaves crude water extracts (mg/mL) from Nigeria*E. coli*, *Salmonella* Typhi*, S. aureus*505.0[@bib0010]Leaves crude ethanol extracts (mg/mL) from Nigeria*Proteus mirabilis, Klebsiella pneumoniae*252.5Leaves crude acetone extracts (mg/mL) from Nigeria*E. coli,*505.0*Salmonella* Typhi*, S. aureus*, *Klebsiella pneumoniae*252.5*Proteus mirabilis*151.5*E. coli*, *Klebsiella pneumoniae*252.5*Salmonella* Typhi*, S. aureus*, *Proteus mirabilis*151.5Leaves essential oil (mg/mL) from Egipt*S. aureus*0.70.07[@bib0790]*P. aeruginosa*3.120.312Leaves DMSO extract (μg/mL) from JordanNewcastle Disease Virus (NDV)50-5000.005-0.05[@bib0040]Leaves methanol extract (μg/mL) from IsraelIC50IC50[@bib0015]Herpes simplex virus -10.1±0.08 0.3±0.020.00001±0.000008Herpes simplex virus -21±0.030.00003±0.000002Varicella-Zoster Virus0.0001±0.000003Leaves methanol extracts from NigeriaPoliovirus type Ineutralization index of one log and above[@bib0030]Coxsackievirus BEchovirus 6Bark n-butanol extract (μg /mL) from Egypt*P. carotovorum*160.0016[@bib0365]*R. solanacearum*1250.0125*A. tumefaciens*2500.025*Dickeya* spp.5000.05Leaves methanol extracts (mg/mL) from Iran*Microsporum canis*0.86.40.080.64[@bib0395]*M. gypseum*1.63.20.160.32*Tricophyton rubrum*1.61.60.160.16*T. schoenleinii*0.40.80.040.08*T. mentagrophytes*0.20.80.020.08*Epedermophyton floccosum*0.20.80.020.08Bark dichloromethane: methanol extract; aqueous extract (mg/mL) from South AfricaMIC~D:M~MIC~AQ~MIC~D:M~MIC~AQ~[@bib0655]*S. aureus* (3 strains, including MRSA)0.25--1.00.5--0.630.025--0.10.05--0.063*S. epidermidis*0.52.00.050.2*P. aeruginosa*2.04.00.20.4*C. albicans*0.52.00.050.2*Brevibacillus agri*0.250.200.0250.02*Propionobacterium acnes*0.102.00.010.2*Trichophyton mentagrophytes*1.01.00.10.1*M. canis*4.02.00.40.2Leaves methanol and aqueous extracts (μg/mL) from Iran*Leishmania major*IC50IC50[@bib0725]586.2-1108.60.05862--0.11086Leaves crude, diethyl ether, ethyl acetate, aqueous (mg/mL) from Iran*Trichomonas vaginalis*100% growth inhibition with 12.5--50; 24--72 h100% growth inhibition with 1.25--5%; 24--72 h[@bib0480]Leaves wather and ethanolic extracts (μg/mL) from Iran*Trichomonas vaginalis*Dead for 72 h with 60-90Dead for 72 h with 0.006--0.009%[@bib0980]Leaves aqueous extract (mg/mL) from Iraq*Trichomonas vaginalis*Dead for 24 h with 500Dead for 24 h with 50%[@bib0665][^3]Fig. 2Schematic diagram for re-calculation from microliter or milligram per milliliter to percentage (v/v or w/v).Fig. 2

3.1. Antibacterial effect {#sec0045}
-------------------------

*Eucalyptus camaldulensis* plant extracts and EOs were tested against wide range of bacteria. The most frequently included Gram positive bacterium in screening is *S. aureus*. Minimal inhibitory concentrations in most studies were in range 0.07--0.5% indicating moderately high activity against this bacterium. Beside *S. aureus*, antibacterial effect was confirmed against *B. subtilis* (0.17--0.34%), *M. luteus* (0.2--0.4%), and *S. pyogenes* (0.4--1.1%) ([@bib0785]; [@bib0035]; [@bib0595]; [@bib0580]; [@bib0790]; [@bib0735]). Activity of EOs was examined aginst L. *monocytogenes* in only one study and MIC was not obtained with the highest used concentration of 1.0%, and the same was reported for *Enterococcus durans* ([@bib0035]).

Activity against Gram negative bacteria has been documented in a greater extent and MICs for the most frequently used model organism *E. coli* was in range 0.15--3.2%. Sensitivity of other enterobacteria is similar, with MICs in range from 0.05 to 0.32% for *K. pneumoniae* ([@bib0580]; [@bib0735]), 0.16--0.32% for *Salmonella enterica* subsp. *enterica* serovar Typhimurium ([@bib0580]); 0.35--0.4% for serovars Typhi, Paratyphi, and 0.6% for *S.* Enteritis ([@bib0735]). Other enterobacteria are similarily sensitive: *Shigella soneii* was inhibited with 0.3% of EO ([@bib0735]), while *Proteus vilgaris* was sensitive in a broad range from 0.25% ([@bib0735]) to more than 1.28% ([@bib0580]). The published data for *P. aeruginosa* are in the same range as for *P. vulgaris*, which is not surprising, as both species are generally highly resistant to antimicrobial agents. On the contrary, *A. baumannii* which is also known to be multi-drug resistant, showed sensitivity to EO in a range 0.05--0.1% ([@bib0595]). The lowest MIC among Gram negative bacteria was recorded for a gastrointestinal pathogen *V. parachaemoliticus* (0.01%) ([@bib0580]).

Although the Gram positive bacteria are consider more sensitive to EOs in comparison to Gram negative, it cannot be applied for essential oils of *E. camaldulensis*, since the most sensitive bacteria are Gram negative -- *A. baumannii* and *V. parahaemolyticus*. The minimal bactericidal concentrations for most bacteria are equal to, or rarely up to 4 times greater than MICs. This low range in MIC/MBC \< 4 indicates that *E. camaldulensis* EOs act as bactericidal agents ([@bib0755]).

Antibacterial effects of *E. camaldulensis* extracts have been examined in a wider extent than essential oils. Inhibitory concentrations varied depending on extraction method, plant properties, and model organism, being in broad range from 0.08 μg/mL to 200 mg/mL. Crude aqueous leaf extracts show lower activity against various bacteria (range 25--50 mg/mL) ([@bib0010]), while bark aqueous extracts were more effective, with MIC from 0.1 mg/mL for *Propionobacterium acnes* to 4.0 mg/mL for *P. aeruginosa* ([@bib0655]). The antimicrobial activity of methanol, ethanol or petroleum leaf extracts of *E. camaldulensis* showed significant variation; for instance, MICs against *B. subtilis* varied from 0.04 up to 200 mg/mL or against *S. aureus* 1.25--25 mg/mL ([@bib0235]; [@bib0070]). For most examined Gram negative bacteria MICs were in range 10--200 mg/mL, while *P. aeruginosa* was even more susceptible (MICs 10--100 mg/mL). Similar or better antibacterial effect showed acetone leaf extract, being active against examined bacteria in range 15--50 mg/mL. The highest activity was obtained with dichloromethen extracts, with MICs for *Staphylococcus* spp. in range 0.25--1.0 mg/mL, and even lower for *B. subtilis, P. acnes* and *B. agri* (MICs 0.10--0.79 mg/mL). Interestingly, generally highly resistant *M. tuberculosis* was sensitive to methanol, n-hexane or chloroform extract with MICs in range 0.004--0.064 mg/mL, while *M. bovis* was slightly less sensitive with MICs 0.01--0.05 mg/mL ([@bib0615]; [@bib0420]).

The progresses made on the investigation of essential oils mode of action, especially against bacterial cell targets, gave new perspectives in this combat. The knowledge about the essential oils and their target(s) on bacterial cell is crucial to understand which parts of bacterial cell are affected. The essential oils antibacterial action is linked to oil hydrophobicity that increases cell permeability and consequent leakage of cell constituents ([@bib0320]; [@bib0610]; [@bib0485]; [@bib0930]; [@bib0935]; [@bib0400]). It is important to perceive that a disturbed cell structures may affect stability of other cellular structures in a cascade type of action ([@bib0185]). Essential oils have several target sites on bacterial cells; however it seems that all are directly or indirectly connected to the primary effect of essential oils on the bacterial envelopes. First of all, EOs may cause cell wall and membrane disturbance ([@bib0610]; [@bib0740]), which further can lead to the significant loss of intracellular ATP ([@bib0740]; [@bib0930]), induction the synthesis of heat shock proteins ([@bib0170]), pH disturbance ([@bib0930]; [@bib0740]), and intracytoplasmic changes (*e.g.* coagulation, periplasmic space enlargement) ([@bib0105]). Although the number of studies dealing with the EO mechanisms of action is increasing, there are still many questions to be answered before the precise mechanism is revealed. This is at the same time one of the main limitations for EOs and extracts wide usage as antimicrobials. Thus, the so far knowledge must be further improved enabling the combat bacterial pathogens and its resistance.

Contemporary research of EOs and extracts are also focused on mechanism that allows bacteria to regulate some physiological activities, such as virulence, competition amongst populations, motility, sporulation, conjugation, antibiotic production, and bioﬁlm formation ([@bib0800]). This system of intercellular communication, quorum sensing (QS), is based on production of the signal molecules, called autoinducers ([@bib0005]). This communication system is relative to cell density and some compounds interfere with the QS communication system and attenuating the bacterial pathogenicity, in the phenomenon known as anti-QS compounds ([@bib0005]). There are reports of anti-QS activity of various plants species EOs from genus *Eucalyptus*, such as *Eucalyptus globulus* L. ([@bib0645]; [@bib0190]), *Eucalyptus radiata* D. ([@bib0645]), *Eucalyptus citriodora* Hook., *Eucalyptus smithii* R. T. Baker and *Eucalyptus staigeriana* F. Muell. ex Bailey ([@bib0645]). Unfortunately, there is still no data regarding *E. camaldulensis* anti-QS activity.

In one study, antibacterial and *in vivo* biofilm preventive efficacies of *E. camaldulensis* oil were significantly higher than that of *M. spicata* oil and chlorhexidine, suggesting that *E. camaldulensis* EO is capable of affecting biofilm formation ([@bib0785]). Considering the anti-QS activity of above mentioned *Eucalyptus* species and also detected antimicrobial and anti-biofilm effect of *E. camaldulensis* it can be assumed that it possess similar or even higher anti-QS activity. However, future detailed studies of anti-QS and anti-biofilm *E. camaldulensis* activity are needed in order to confirm this assumption.

3.2. Antifungal effect {#sec0050}
----------------------

The *E. camaldulensis* leaves extracts and EOs have a potential as antifungal agents. They are able to act as a moderate antifungal agent against household molds, wood rot fungi ([@bib0865]), and phytopathogenic fungi ([@bib0415]; [@bib0680]).

*Eucalyptus camaldulensis* EO has been studied for antifungal activity and was active in concentration 0.125--1.0% against most model organisms. The most sensitive seems to be *F. sporotrichioides* with MIC 0.125% ([@bib0680]), while *R. oryzae* is the most resistant, as 1% of EO was ineffective against this fungus ([@bib0865]). The best known human and animal pathogenic yeast *Candida* sp. showed considerable sensitivity to *E. camaldulensis* EO, with MIC approx. 0.5% ([@bib0865]; [@bib0720]). Most EOs from Sardinia inhibited growth of *A. niger* and *B. cinerea* in concentration of 20 μL/plate, while lower concentrations of the oils, such as 5 μL/plate were ineffective ([@bib0095]).

It is interesting to notice that liposomes containing *E. camaldulensis* EO were prepared ([@bib0690]) for antifungal oil activity. The particle size varied from 40.5 to 298 nm for the different formulations, with approx. 95% of the essential oil entrapped. Inhibition of *Microsporum canis, M. gypseum, Trichophyton rubrum,* and *T. verrucosum* was achieved with 125 μL, and the liposomal gel formulation of the EO was proposed to improve antifungal activity.

Aqueous and organic extracts of *E. camaldulensis* have been reported to have antifungal activity ([Table 4](#tbl0020){ref-type="table"}). Methanol leaves extracts showed inconsistent activity against *C. albicans*: in one study it was in range 50--200 mg/mL ([@bib0235]), while in another it was 0.2 mg/mL ([@bib0080]), indicating difference in active concentration of one thousand times. The bark methanole extract was active in concentration 0.5 mg/mL. Methanol leaf and bark extracts showed considerable activity against dermatophytes: 0.8--1.6 mg/mL against *Microsporum* spp, 0.125--1.6 mg/mL against *Trichophyton* spp., and 0.2 mg/mL against *Epidemophyton flocossum* ([@bib0900]; [@bib0395]; [@bib0655]).

Beside the antifungal activity of EOs and extracts of *E. camaldulensis*, it is worth noticing that this species, along with *E. blakelyi* M.*, E. gomphocephala* A. DC*, E. rudis* Endl., and *E. tereticornis* Sm., is a reservoir of an emerging pathogenic fungus -- *Cryptococcus gattii*. This fungus is usually related to tropic and subtropic regions, affecting the respiratory and nervous systems of the immunocompetent humans and domestic animals ([@bib0885]; [@bib0195]; [@bib0115]; [@bib0805]). Similarily, *C*. *neoformans* var*. grubii* can be isolated from flowers and bark of *E. camaldulensis* ([@bib0455]). According to the literature, *E. camaldulensis* is natural reservoir of *Cryptococcus* and is considered responsible for occurring cryptococcosis worldwide. In this context, it is interesting to observe that *C. neoformans* is moderately sensitive to *E. citriodora* Hook EOs, with MIC90 0.5% (wt/v) ([@bib0765]; [@bib0650]) or *E. globulus* Labill. with MIC 0.13% (wt/v) ([@bib0890]). Unfortunately, data on *Cryptococcus* sp. sensitivity to EOs and plant extracts of reservoir species of *Eucalyptus*, including *E. camaldulensis*, remains unknown.

Although there are no reports regarding *E. camaldulensis* mode of antifungal action, according to previous studies with other essential oils and fungi, the plasma membrane and the mitochondria are the probable antifungal targets of EOs. According to recent studies, the antifungal activity of EOs results from its ability to disrupt the permeability barrier of the plasma membrane and from the mitochondrial dysfunction-induced ROS accumulation in A. flavus and *C. albicans (* [@bib0915]; [@bib0215]). The exact mechanism of *E. camaldulensis* antifungal activity is unknown and should be elucidated in the future.

3.3. Antiviral effect {#sec0055}
---------------------

Infections caused by viruses are very common and sometimes life threatening, especially in immunocompromised patients and neonates ([@bib0880]; [@bib0575]). Despite the recent significant progress in antiviral drug development, viral infections are considered as one of the major causes of death worldwide ([@bib0705]; [@bib0685]). Thus, novel natural antiviral agents need to be found urgently. Many natural products possess antiviral activity and some of them are already in use for treatment of human viral infections with both RNA and DNA viruses (*e.g.* myricetin against coronavirus, linalool, urosolic acid, and apigenin against coxsackievirus, quercetin and narasin against denge virus, curcumin against hepatitis B and C virus) ([@bib0635]; [@bib0590]). Numerous secondary plant metabolites such as essential oils, flavonoids, saponins, tannins, alkaloids, lignans, terpenes, and phenolic acids express significant antiviral activity against different viruses ([@bib0530]; [@bib0225]; [@bib0820]). Recently few studies confirmed the *E. camaldulensis* EOs and plant extracts antiviral activity ([Table 4](#tbl0020){ref-type="table"}).

*Eucalyptus camaldulensis* EOs reduce coxackie B4 and rotavirus Wa multiplication for 50%, herpes simplex virus 1 for 90%, but have no effect on adenovirus 7 multiplication ([@bib0345]). Similarly, methanolic extracts showed 50% inhibition of HSV 1 and 2 in concentration 0.1--0.3 μg/mL, and against Varicella zoster virus at concentration 1.0 μL/ml ([@bib0015]). Dimethyl sulfoxide (DMSO) extracts inhbit multiplication of animal New Castle virus in concentration range 50--500 μg/mL ([@bib0040]). Antiviral activity has been observed for *E. camaldulensis* methanolic extracts against polio virus, coxsackie B, and echovirus 6 ([@bib0030]). The data on antiviral activity of *E. camaldulensis* EO and extracts, although scarce, indicate their great potential, and necessity for further studies in this context.

Despite the fact that many plant extracts and essential oils were previously reported for their antiviral activities, the mechanism of action still remains poorly understood. There are many factors that influencing the EOs mode of action, which should be taken in consideration when antiviral activity of plant antimicrobials is examined. One of such factors is the difference between enveloped and non-enveloped viruses, because the observed antiviral effect has usually been greater for enveloped viruses ([@bib0965]; [@bib0845]). In majority of the studies dealing with antiviral mode of action, the focus has been on either the inhibition of viral adsorption to host cells or examination of the plant antimicrobials effectiveness against intracellular virus multiplication ([@bib0450]). So, most commonly described modes of antiviral actions are virus inactivation and the impaired virus adsorption to host cells, which is often difficult to distinguish. Like in other antimicrobial modes of action, antiviral mechanism is also dependent on EOs or extracts compounds activity. This is one more factor that should be considered, because it affects the final antiviral mechanism of action. For some compounds the potential mechanism is reported, *i.e.* carvacrol acts directly upon the virus capsid and subsequently the nucleic acid ([@bib0450]). When EOs antiviral mechanism of action is considered, EOs may cause the loss of the viral capsid integrity, ultimately leading to exposure of the viral genome. In addition, some EOs subsequently act directly upon the viral nucleic acid (DNA or RNA). According to one study, *E. camaldulensis* EOs may be promising antiviral agent against RNA viruses with no effect against DNA virus ([@bib0345]). Also, with shorter periods of exposure to the antimicrobial, the virus is able to adsorb specifically to host cells; however, it may or may not be able to cause successful infection depending upon the integrity of the viral genome. On the other hand, after exposure to some EOs virus capsid and genome remains intact. These antimicrobials appear to exert their antiviral effect by coating the capsid and thereby preventing specific adsorption of the virus to host cells ([@bib0450]). Although, there are still no reports regarding *E. camaldulensis* EOs antiviral mode of action, there are some promising results about its antiviral effect ([Table 4](#tbl0020){ref-type="table"}). These promising results represent foundation for further research and potential application of *E. camalulensis* EOs as potent antiviral agent.

3.4. Antiprotzoal effect {#sec0060}
------------------------

Among all deverse benefitial activities, *E. camaldulensis* expresess also an antiprotozoal effect as well. The reports regarding this effect are listed in [Table 4](#tbl0020){ref-type="table"}. *Eucalyptus camaldulensis* methanolic and aqueous extracts were active against *Leishmania major* with IC50 values (50% inhibitory concentration) 586.2 ± 47.6 and 1108.6 ± 51.9 μg/mL, respectively ([@bib0725]). This was characterized as moderate leishmanicidal activity, but considering fact that present therapy consist antimony compounds which are expensive, toxic, and drug resistance is prevalent, *E. camaldulensis* plant extract derivatives represent safe, inexpensive, and promising alterantive solution.

There are also several reports regarding antiprotozoal activity against *Trichomonas vaginalis*, a causative agent of trichomoniasis which is the most prevalent nonviral sexual infection. The first report on *E. camaldulensis* aqueous extract anti-trichomonas activity showed that extract was active at concentration 500 mg/mL after 24 h ([@bib0665]). However, recent studies reported better effect of the *E. camaladulensis* extracts ([@bib0480]; [@bib0980]). Five different *E. camaldulensis* leaves extracts including total extract, diethyl ether, chloroform, ethyl acetate, and water fractions were active in concentration range 12.5--50 mg/mL, with growth inhibiton achived after 24--72 h ([@bib0480]). Ethyl acetate fraction showed the highest percentage of growth inhibition with the lowest concentration (12.5 mg/mL) after 24 and 48 h ([@bib0480]). Even better anti-trichomonas activity was detedted for wather and ethanolic extracts, where concentration 60--90 μg/mL killed *Trichomonas vaginalis* for 72 h ([@bib0980]). The mainstay medication for trichomoniasis is metronidazole; however some resistant strains to this treatment have been detected making these results of *E. camaldulensis* anti-trichomonas activity very promising as antiprotozoal agent.

Except extracts, significant antiprotozoal activity was reported for *E. camaldulensis* EOs. The essential oils were found to possess antitrypanosomal activity *in vitro* in a dose-dependent manner in a short time. The decrease of *Trypanosoma evansi* number over time was achieved in doses of 400 mg/mL for 3 min, 200 mg/mL for 4 min, and 100 mg/mL for 15 min. Against *Trypanosoma brucei brucei* EOs was more potent in the concentration of 400 mg/mL, decreasing the number of parasite for 3 min, 200 mg/mL for 4 min, and 100 mg/mL for 11 min ([@bib0460]). Such prompt decrease in parasite number in the *in vitro* tests for both *Trypanosoma brucei brucei* and *T. evansi*suggests that the EOs kill the parasites efficiently, but by an unknown mechanism. There are suggestions of some potential mechanisms of antiprotozoal EOs action. The activity of EOs could be due to the hydrophobic nature of the cyclic hydrocarbons, which allow EOs to interact with the protozoans causing conformational changes in the parasite membrane structure, resulting in the loss of membrane stability ([@bib0180]). The essential oils also can act by inhibiting some key enzymes in the parasite glycolytic pathway ([@bib0875]). Furthermore, some EOs components inhibit acetylcholinesterase activity and act on other vulnerable sites, such as cytochrome p450 ([@bib0660]). This multicomponent nature of plant EOs is an advantage for several target sites on protozoans, which is of great importance.

3.5. Antimicrobial activity of *E. camaldulensis* Dehn. *vs.* other species of genus *Eucalyptus* {#sec0065}
-------------------------------------------------------------------------------------------------

It was shown that EOs of *E. camaldulensis* are more potent against *B. subtilis*, *S. aureus*, *E. coli*, *P. aeruginosa*, *S. lutea,* and *P. carotovorum* in comparison to EOs from *E. gomphocephala* DC., but not against *A. tumefaciens*. Furthermore, the *E. camaldulensis* var. *obtuse* showed even better effect than *E. camaldulensis* ([@bib0815]). Among seven examine essential oils of various *Eucalyptus* species, EO of *E. camaldulensis* was among the best against *B. subtilis*, *A. niger,* and *R. solani*, but not against *E. coli* and *S. aureus* ([@bib0425]). Similar activity of *E. camaldulensis* and *E. torelliana* F. Muell. was recorded for extracts against six strains of *H. pylori* ([@bib0025]).

It is worth to notice that among 132 extracts from 42 plants growing in southern Africa, *E. camaldulensis* bark extract showed considerable activity against bacteria and fungi, with an exception against *P. aeruginosa* and *M. canis* ([@bib0655]). Finaly, in many studies regarding antimicrobial activity of various *Eucalyptus* species, *E. camaldulensis* was not always included ([@bib0055]; [@bib0810]; [@bib0710]; [@bib0335]; [@bib0830]).

4. Interaction of *Eucalyptus camaldulensis* Dehn. EOs/extracts and other antimicrobial agents {#sec0070}
==============================================================================================

Due to rapid emerging of microbial resistance to conventional drugs, the necessity for efficient solution(s) is rising. The main strategy represents finding new antimicrobial agents; however another strategy goes in the direction of reducing degree of bacterial resistance and/or bacterial re-sensitization to conventional antibiotics. This can be achieved using combined therapies. The most of the tested combinations are dual combinations, but the combinations of three, four or more agents also can be efficient ([@bib0625]). This is in line with antimicrobial efficiency and potential of EOs and plant extracts which are complex mixtures of numerous compounds. Combination strategy could be very promising regarding the diversity of agents that could be tested: (1) conventional non-antimicrobial agent (*e.g.* anti-inflammatory or anti-psychotic drug) + conventional antimicrobial agent (antibiotic); (2) conventional antimicrobial agent (antibiotic) + natural antimicrobial agent (essential oil, plant extract, bacteriophage, antimicrobial peptide ect.); (3) conventional antimicrobial agent (antibiotic) + single compound isolated from natural antimicrobial agent (with previously confirmed antimicrobial activity); (4) combination of two or more single compounds isolated from natural antimicrobial agents (with previously confirmed antimicrobial activity).

Being a plant with already detected and evaluated antimicrobial activity, it can be assumed that *E. camaldulensis* also have a potential in combined therapy. This assumption is confirmed in some studies *in vitro* and *in vivo* ([Table 5](#tbl0025){ref-type="table"} ). *Eucalyptus camaldulensis* EOs and extracts *in vitro* reduced resistance of MDR *A. baumannii* in combination with conventional antibiotics: β-lactams, ciprofloxacin, gentamicin, polymyxin B ([@bib0595]). Similarily, the increase of β-lactamase produing MRSA and *E. coli* sensitivity to cephalexin, cefuroxime, amoxicillin, and ampicillin has been obtained through combination with *E. camaldulensis* EOs ([@bib0210]). Synergistic activity has been recorded between *E. camaldulensis* plant extracts and gentamicin or ceftriaxone against MDR *S. aureus* and *P. aeruginosa* ([@bib0790]; [@bib0500]), as well as in combination with ampicillin against *S. aureus* ([@bib0500]).Table 5Effects of *Eucalyptus camaldulensis* and other antimicrobial agents in combination.Table 5*E. camaldulensis* extract or essential oilAntimicrobial agent(s) in combinationTest organismMethodEffect of combinationReferenceLeaf essential oils from MontenegroCiprofloxacin, Gentamicin, Polymyxin BReference *Acinetobacter baumannii* and MDR clinical strainsTwo-dimensional checkerboard method ([@bib0945])Synergism (FICI ≤ 0.5)[@bib0595])Leaf essential oil from BrazilCephalexin*Staphylococcus aureus* 29The MIC of the antibiotics were determined in the presence and absence of sub-inhibitory concentrations (125 μg mL^−1^) of the essential oil ([@bib0275])Combining the essential oil with β-lactams reduced the resistance of tested strains[@bib0210])Cefuroxime*S. aureus* 55 (MRSA) *E. coli* (all strains resistant to β-lactam antibiotics)AmoxicillinAmpicillinLeaf methanol extract (0.01 μg/mL) from IsraelAcyclovir (0.01 μg/mL)*In vitro* infection of Vero cells with Herpes simplex virus -1 Herpes simplex virus -2 Varicella-Zoster VirusTreating the cells with different combinations of the extract and acyclovir at the time and post-infection with the virusSignificant inhibition (˜75%) of the viral infection, comparing to single agent (10-20%)[@bib0015])Leaf methanol extract from NigeriaLeaf methanol extracts of *Annona senegalensisIn vivo* albino mice infection with *Trypanosoma brucei brucei* (Lafia strain)200 mg/kg bodyweight/day (for 21 days) of crude methanol extracts of *A. senegalensis* and *E. camaldulensis* combinations in ratios 1:1, 1:2, and 2:1, respectively.Synergism (only the combination 1:1 resulted in the complete clearance of parasites from the circulation of animal)[@bib0550])Leaf methanol extract from EgyptGentamicin, CeftriaxoneMDR *S. aureus*[@bib0605])Synergism[@bib0790])MDR *P. aeruginosa*Leaf acetone extract from NigeriaAmpicillinMDR S. aureus[@bib0255])Synergism[@bib0500])CiprofloxacinLeaf ethanol extract from Nigeria*Psidium guajava* ethanol extract*E. coli*Agar disc diffusion method was employed as described by [@bib0585]), adopted by [@bib0985] and [@bib0100]Synergism[@bib0085])MDR *S. aureus*

Furthermore, the combination of *E. camaldulensis* extract with another plant extract *Psidium guajava* L. was also efficient against MDR bacteria ([@bib0085]). Except antibacterial activity, other activities of *E. camaldulensis* extracts in combination were detected and characterized as efficient. Antiviral activity was confirmed for the combination of *E. camaldulensis* 80% methanol leaves extract and acyclovir against herpes simplex virus -1 and -2 and varicella-zoster virus ([@bib0015]). Similaily, the combination of *Annona senegalensis* L. leaf methanol extract and *E. camaldulensis* extract efficiently cured *in vivo* albino mice infection with parasite *Trypanosoma brucei brucei* (Lafia strain) ([@bib0550]). All these data are very promising, but the methods used in different studies and results interpretation vary ([Table 5](#tbl0025){ref-type="table"}). As a consequence, the data should be taken with precautions, as can not be compared and properly discussed. To avoid this problem, the testing combinations of different agents should be conducted using standardized methods, such as time-kill method ([@bib0245]; [@bib0945]), checkerboard method ([@bib0945]; [@bib0385]), Chou-Talalay method ([@bib0230]) or Boik method ([@bib0130]). All these methods possess some shortfalls, such as time-consuming, labor-intensive, limitations regarding the number of the agents in combination, *etc.* Unfortunately, there is no one gold standard for synergy testing and prior the further application of different phytochemicals, this issue should be overcome.

5. Conclusion {#sec0075}
=============

Summarizing the available data on antimicrobial properties of *Eucalyptus camaldulensis* essential oil and extracts, it is obvious that this plant is a valuable source of phytotherapeutics. The essential oil, as well as leaf and bark extracts are particularly valuable as antibacterial, antiviral, and antifungal agents, and their antiprotozoal activity should not be neglected taking into account current therapy cost, toxicity, and protozoal growing resistance. Some *E. camaldulensis* plant characteristics such as easy cultivation, wide distribution by plantation, and rapid growth additionally support further examination of antimicrobial activity, in order to enhance the commercial production of *E. camaldulensis* based pharmaceuticals. The future studies should be focused on determination of the mechanisms of antimicrobial activity, paticularly potential anti-biofilm and anti-QS effects, as well as the activity enhancement in combination with other available agents.
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[^1]: L- leaf, Fr-fruit, Fl-flower.

[^2]: tr., traces (\<0.05%).

[^3]: MIC -- minimal inhibitory concentration, MBC -- minimal bactericidal concentration, GI -- growth inhibition, IC50 - 50% inhibitory concentration.
